HKI-272 for HER2-Positive Breast Cancer and Brain Metastases
Clinical trial NCT01494662 · COMPLETED
Trial details
- NCT number
- NCT01494662
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2023-02-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.